An Exploratory Study on the Application of Transarterial CT Angiography in the Interventional Treatment of Massive Hemoptysis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-28

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a single-arm, exploratory study to evaluate the value of transarterial CT angiography applying Nexaris Angio-CT in the interventional treatment of massive hemoptysis

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors

NCT05673031

Neuroendocrine Tumors (NET)

RECRUITING

68Ga-DOTATATE PET/CT in Neuroendocrine Tumor

NCT04041882

Neuroendocrine Tumors

UNKNOWN EARLY_PHASE1

TF-antigen Targeting Molecular Probe for PET Imaging in Solid Tumors

NCT06755086

Solid Tumors

NOT_YET_RECRUITING

PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy

NCT00019565

Unspecified Adult Solid Tumor, Protocol Specific

COMPLETED PHASE1

Clinical Application of 68Ga-FL-031 PET in the Diagnosis and Staging of Malignant Tumors

NCT07301801

Malignant Tumors SSTR2 PET

RECRUITING EARLY_PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemoptysis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Transarterial CT angiography

Transarterial catheter-directed CT angiography during interventional treatment of hemoptysis

Group Type EXPERIMENTAL

Transarterial CT angiography

Intervention Type DEVICE

Transarterial catheter-directed CT angiography during interventional treatment of hemoptysis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transarterial CT angiography

Transarterial catheter-directed CT angiography during interventional treatment of hemoptysis

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with massive hemoptysis（defined as more than 100mL per session or more than 300mL/day or with acute respiratory failure requiring mechanical ventilation or hemodynamic instability (systolic blood pressure \< 90 mmHg), regardless of hemoptysis amount）

Exclusion Criteria

* Pregnancy
* Patients with a previous history of bronchial artery embolization
* Uncorrectable severe infection, coagulation dysfunction, organ failure or cachexia, severe contrast agent allergy, and other interventional treatment contraindications

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No